Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Dow
Boehringer Ingelheim
Colorcon
Express Scripts

Last Updated: October 1, 2022

AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Ammonium Chloride 0.9% In Normal Saline, and when can generic versions of Ammonium Chloride 0.9% In Normal Saline launch?

Ammonium Chloride 0.9% In Normal Saline is a drug marketed by Mcgaw and is included in one NDA.

The generic ingredient in AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE is ammonium chloride. There are forty drug master file entries for this compound. Additional details are available on the ammonium chloride profile page.

Summary for AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE
Drug patent expirations by year for AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE
Recent Clinical Trials for AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Mercy Hospital Kansas CityPhase 1
American Heart AssociationPhase 1
University Hospitals Cleveland Medical CenterN/A

See all AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE clinical trials

US Patents and Regulatory Information for AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcgaw AMMONIUM CHLORIDE 0.9% IN NORMAL SALINE ammonium chloride INJECTABLE;INJECTION 006580-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Baxter
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.